Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes.

BMC medical genetics - 25 Aug 2010

Jiang Yi-Der, Chang Yi-Cheng, Chiu Yen-Feng, Chang Tien-Jyun, Li Hung-Yuan, Lin Wen-Hsing, Yuan Hsiang-Yu, Chen Yuan-Tsong, Chuang Lee-Ming

Abstract excerpt

BACKGROUND: Recent data indicate that loss-of-function mutation in the gene encoding the facilitative glucose transporter GLUT10 (SLC2A10) causes arterial tortuosity syndrome via upregulation of the TGF-β pathway in the arterial wall, a mechanism possibly causing vascular changes in diabetes. MET...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus, Type 2
Share to Diabetic Angiopathies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glucose Transport Proteins, Facilitative

Share to Longitudinal Studies

Share to Odds Ratio

Share to Peripheral Vascular Diseases

Share to Transforming Growth Factor beta

Source

Open in PubMed Open full text

Identifiers

PMID: 20735855
DOI: 10.1186/1471-2350-11-126
PMCID: PMC2939510

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20735855-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SLC2A10 genetic polymorphism predicts development of peripheral arterial disease in patients with type 2 diabetes. SLC2A10 and PAD in type 2 diabetes.PMID 20735855Read ↗

Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome.Semantic proximity Read ↗

Arterial tortuosity syndrome: clinical and molecular findings in 12 newly identified families.Semantic proximity Read ↗

Mutations in the SLC2A10 gene cause arterial abnormalities in mice.Semantic proximity Read ↗

Two novel SLC2A10/GLUT10 mutations in a patient with arterial tortuosity syndrome.Semantic proximity Read ↗

GLUT10 deficiency leads to oxidative stress and non-canonical αvβ3 integrin-mediated TGFβ signalling associated with extracellular matrix disarray in arterial tortuosity syndrome skin fibroblasts.Semantic proximity Read ↗

Arterial tortuosity syndrome in two Italian paediatric patients.Semantic proximity Read ↗

A novel missense and a recurrent mutation in SLC2A10 gene of patients affected with arterial tortuosity syndrome.Semantic proximity Read ↗

Association study of genetic polymorphisms of SLC2A10 gene and type 2 diabetes in the Taiwanese population.Semantic proximity Read ↗

A Genetic Locus on Chromosome 2q24 Predicting Peripheral Neuropathy Risk in Type 2 Diabetes: Results From the ACCORD and BARI 2D StudiesSemantic proximity Read ↗

Genetic variation of the GLUT10 glucose transporter (SLC2A10) and relationships to type 2 diabetes and intermediary traits.Semantic proximity Read ↗

Glucose transporter 10 and arterial tortuosity syndrome: the vitamin C connection.Semantic proximity Read ↗

Association of prostaglandin E synthase 2 (PTGES2) Arg298His polymorphism with type 2 diabetes in two German study populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.